LDE225 Diphosphate 25mg 25mg | Purity Not Available
Adooq Bioscience
LDE225 is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity.
More Information Supplier PageSearch Results
LDE225 Diphosphate 10mg 10mg | Purity Not Available
Adooq Bioscience
LDE225 is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity.
More Information Supplier PageBleomycin hydrochloride 50mg 50mg | Purity Not Available
Adooq Bioscience
Bleomycin hydrochloride is an antitumor antibiotic which induces apoptosis.
More Information Supplier PageBleomycin hydrochloride 5mg 5mg | Purity Not Available
Adooq Bioscience
Bleomycin hydrochloride is an antitumor antibiotic which induces apoptosis.
More Information Supplier PageBleomycin hydrochloride 25mg 25mg | Purity Not Available
Adooq Bioscience
Bleomycin hydrochloride is an antitumor antibiotic which induces apoptosis.
More Information Supplier PageBleomycin hydrochloride 10mg 10mg | Purity Not Available
Adooq Bioscience
Bleomycin hydrochloride is an antitumor antibiotic which induces apoptosis.
More Information Supplier PageAcolbifene (EM 652, SCH57068) 50mg 50mg | Purity Not Available
Adooq Bioscience
acolbifene is a substance being studied in the prevention of breast cancer in women at high risk of breast cancer. Acolbifene hydrochloride binds to estrogen receptors in the body and blocks the effects of estrogen in the breast. It is a type of selective estrogen receptor modulator (SERM).
More Information Supplier PageAcolbifene (EM 652, SCH57068) 5mg 5mg | Purity Not Available
Adooq Bioscience
acolbifene is a substance being studied in the prevention of breast cancer in women at high risk of breast cancer. Acolbifene hydrochloride binds to estrogen receptors in the body and blocks the effects of estrogen in the breast. It is a type of selective estrogen receptor modulator (SERM).
More Information Supplier PageLDE225 Diphosphate 50mg 50mg | Purity Not Available
Adooq Bioscience
LDE225 is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity.
More Information Supplier PagePF-5274857 10mg 10mg | Purity Not Available
Adooq Bioscience
PF-5274857 is a novel Smo antagonist that specifically binds to Smo with a K(i) of 4.6 ?? 1.1 nmol/L and completely blocks the transcriptional activity of the downstream gene Gli1 with an IC(50) of 2.7 ?? 1.4 nmol/L in cells.
More Information Supplier Page